436 related articles for article (PubMed ID: 31570110)
1. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma.
Hazlewood RJ; Kuchtey J; Wu HJ; Kuchtey RW
Invest Ophthalmol Vis Sci; 2020 May; 61(5):51. PubMed ID: 32460313
[TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss.
Echevarria FD; Formichella CR; Sappington RM
Front Neurosci; 2017; 11():318. PubMed ID: 28620279
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of a dual ET
Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
[TBL] [Abstract][Full Text] [Related]
6. Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.
Wareham LK; Dordea AC; Schleifer G; Yao V; Batten A; Fei F; Mertz J; Gregory-Ksander M; Pasquale LR; Buys ES; Sappington RM
Neurobiol Dis; 2019 Jan; 121():65-75. PubMed ID: 30213732
[TBL] [Abstract][Full Text] [Related]
7. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
[TBL] [Abstract][Full Text] [Related]
9. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
[TBL] [Abstract][Full Text] [Related]
10. Sigma-1 receptor agonist, (+)-pentazocine, is neuroprotective in a Brown Norway rat microbead model of glaucoma.
Mysona BA; Zhao J; De Greef O; Beisel A; Patel PA; Berman L; Smith SB; Bollinger K
Exp Eye Res; 2023 Jan; 226():109308. PubMed ID: 36400283
[TBL] [Abstract][Full Text] [Related]
11. Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.
Matsumoto Y; Kanamori A; Nakamura M; Negi A
Jpn J Ophthalmol; 2014 May; 58(3):290-7. PubMed ID: 24610540
[TBL] [Abstract][Full Text] [Related]
12. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.
Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ
Exp Eye Res; 2011 Apr; 92(4):299-305. PubMed ID: 21272576
[TBL] [Abstract][Full Text] [Related]
13. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.
Steinhart MR; Cone FE; Nguyen C; Nguyen TD; Pease ME; Puk O; Graw J; Oglesby EN; Quigley HA
Mol Vis; 2012; 18():1093-106. PubMed ID: 22701298
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
[TBL] [Abstract][Full Text] [Related]
17. The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma.
Cone FE; Steinhart MR; Oglesby EN; Kalesnykas G; Pease ME; Quigley HA
Exp Eye Res; 2012 Jun; 99(1):27-35. PubMed ID: 22554836
[TBL] [Abstract][Full Text] [Related]
18. A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma.
Cammalleri M; Dal Monte M; Amato R; Bagnoli P; Rusciano D
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32340314
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure.
Madeira MH; Elvas F; Boia R; Gonçalves FQ; Cunha RA; Ambrósio AF; Santiago AR
J Neuroinflammation; 2015 Jun; 12():115. PubMed ID: 26054642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]